Arrhythmias

2020; 21(6): 14-20

Screening for atrial fibrillation: the essential role of GPs

KATRINA GISKES, CHARLOTTE HESPE, BEN FREEDMAN

2019; 20(11): 10-16

Atrial fibrillation management. The central role of the GP

David Brieger, CIA CONNELL, CHARLOTTE HESPE, Nicholas Zwar

Emergency medicine

2018; 19(5): 66-68

Holiday heart: mobile app suggests atrial fibrillation after ‘a few drinks’

Sascha Fulde, Gordian Fulde

2017; 18(5): 33-40

Managing patients after implantation of a cardiac rhythm management device

HITESH C. PATEL, HARIHARAN RAJU, Alex Voskoboinik, JUSTIN A. MARIANI

Drug update

2016; 17(11): 63-65

Idarucizumab: an anticoagulant reversal agent for dabigatran

Anthony FT Brown, Harshal Nandurkar

Clinical investigations from the RACP

2015; 16(10): 43-47

The patient with palpitations: cardiac, systemic or psychosomatic?

Liang-han Ling, Peter Kistler

2015; 16(7): 25-32

Practical use of the nonvitamin K antagonist oral anticoagulants

Alex Madden, Harry Gibbs

2015; 16(6): 14-24

NOACs in cardiovascular disease: what is their role?

Jyotsna Janardan, Harry Gibbs

Drug update

2013; 14(3): 69-75

Dabigatran etexilate for preventing stroke and systemic embolism in atrial fibrillation

Alex Gallus, Joanne Judd

2012; 13(10): 16-26

Recent advances in the treatment of atrial fibrillation

Saurabh Kumar, Jonathan M Kalman

2009; 10(8): 18-28

Management of atrial fibrillation

Martin Stiles, Prashanthan Sanders

2004; 5(2): 41-51

Current management of atrial fibrillation

David Gallagher

2003; 4(4): 18-25

Contemporary management of tachyarrhythmias

Stuart P Thomas

Clinical investigations from the RACP

2000; 1(5): 97-100

Investigating the patient with bradycardia

David Amos